miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation

Experimental Hematology

Volumn 37, Issue 2, 2009, Pages 245-255

  Schaar, Dale G ^a   Medina, Daniel J ^a   Moore, Dirk F ^a   Strair, Roger K ^a   Ting, Yi ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; MICROR 320; MICRORNA; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; STEREOTYPY;

ANTIGENS, CD; CARCINOGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; RECEPTORS, TRANSFERRIN; TETRADECANOYLPHORBOL ACETATE;

VERTEBRATA;

EID: 58149201058     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.10.002     Document Type: Article

References (52)

1. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
2. Chen C.Z., and Lodish H.F. MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol 17 (2005) 155-165
3. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
4. Georgantas III R.W., Hildreth R., Morisot S., et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A 104 (2007) 2750-2755
5. Fazi F., Rosa A., Fatica A., et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123 (2005) 819-831
6. Garzon R., Pichiorri F., Palumbo T., et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26 (2007) 4148-4157
7. Gallagher R., Collins S., Trujillo J., et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54 (1979) 713-733
8. Rovera G., Santoli D., and Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A 76 (1979) 2779-2783
9. Huberman E., and Callaham M.F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A 76 (1979) 1293-1297
10. Koeffler H.P., Bar-Eli M., and Territo M. Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. J Clin Invest 66 (1980) 1101-1108
11. Lotem J., and Sachs L. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A 76 (1979) 5158-5162
12. Koeffler H.P., Bar-Eli M., and Territo M.C. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res 41 (1981) 919-926
13. Davis A.F., Meighan-Mantha R.L., and Riegel A.T. Effects of TPA, bryostatin 1, and retinoic acid on PO-B, AP-1, and AP-2 DNA binding during HL-60 differentiation. J Cell Biochem 65 (1997) 308-324
14. Polliack A., Leizerowitz R., Korkesh A., Gurfel D., Gamliel H., and Galili U. Exposure to phorbol diester (TPA) in vitro as an aid in the classification of blasts in human myelogenous and lymphoid leukemias: in vitro differentiation, growth patterns, and ultrastructural observations. Am J Hematol 13 (1982) 199-211
15. White S.L., Belov L., Barber N., Hodgkin P.D., and Christopherson R.I. Immunophenotypic changes induced on human HL60 leukaemia cells by 1alpha,25-dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol-13-acetate. Leuk Res 29 (2005) 1141-1151
16. Cheng Y., Zak O., Aisen P., Harrison S.C., and Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 116 (2004) 565-576
17. Kwok J.C., and Richardson D.R. The iron metabolism of neoplastic cells: alterations that facilitate proliferation?. Crit Rev Oncol Hematol 42 (2002) 65-78
18. Gatter K.C., Brown G., Trowbridge I.S., Woolston R.E., and Mason D.Y. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36 (1983) 539-545
19. Chitambar C.R., Massey E.J., and Seligman P.A. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide. J Clin Invest 72 (1983) 1314-1325
20. Larrick J.W., and Cresswell P. Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct 11 (1979) 579-586
21. Neckers L.M., and Trepel J.B. Transferrin receptor expression and the control of cell growth. Cancer Invest 4 (1986) 461-470
22. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat Genet 37 (2005) 495-500
23. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
24. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 (2006) D140-D144
25. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 32 (2004) D109-D111
26. Draper NR, Smith H. Applied Regression Analysis. New York: New York; 1998.
27. Smirnov I.M., Bailey K., Flowers C.H., Garrigues N.W., and Wesselius L.J. Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity. Am J Physiol 277 (1999) L257-L263
28. Testa U., Pelosi E., and Peschle C. The transferrin receptor. Crit Rev Oncogene 4 (1993) 241-276
29. Rovera G., Ferrero D., Pagliardi G.L., et al. Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action. Ann N Y Acad Sci 397 (1982) 211-220
30. Koeller D.M., Casey J.L., Hentze M.W., et al. A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA. Proc Natl Acad Sci U S A 86 (1989) 3574-3578
31. Fukuda Y., Kawasaki H., and Taira K. Exploration of human miRNA target genes in neuronal differentiation. Nucleic Acids Symp Ser (Oxf) 49 (2005) 341-342
32. Hentze M.W., and Kuhn L.C. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93 (1996) 8175-8182
33. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2 (2006) 406-414
34. May W.S., Sahyoun N., Jacobs S., Wolf M., and Cuatrecasas P. Mechanism of phorbol diester-induced regulation of surface transferrin receptor involves the action of activated protein kinase C and an intact cytoskeleton. J Biol Chem 260 (1985) 9419-9426
35. May W.S., and Tyler G. Phosphorylation of the surface transferrin receptor stimulates receptor internalization in HL60 leukemic cells. J Biol Chem 262 (1987) 16710-16718
36. Taetle R., Ralph S., Smedsrud S., and Trowbridge I. Regulation of transferrin receptor expression in myeloid leukemia cells. Blood 70 (1987) 852-859
37. Shivdasani R.A. MicroRNAs: regulators of gene expression and cell differentiation. Blood 108 (2006) 3646-3653
38. Yee N.S., Hsiau C.W., Serve H., Vosseller K., and Besmer P. Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphatidylinositol 3'-kinase, and protein kinase C. J Biol Chem 269 (1994) 31991-31998
39. Felli N., Fontana L., Pelosi E., et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 102 (2005) 18081-18086
40. Vidal C., Matsushita S., Colamonici O.R., Trepel J.B., Mitsuya H., and Neckers L.M. Human T lymphotropic virus I infection deregulates surface expression of the transferrin receptor. J Immunol 141 (1988) 984-988
41. Tonik S.E., Shindelman J.E., and Sussman H.H. Transferrin receptor is inversely correlated with estrogen receptor in breast cancer. Breast Cancer Res Treat 7 (1986) 71-76
42. Buckshee K., Saha A., Agarwal N., and Singh G. Status of transferrin receptors in benign and malignant lesions of the cervix. Asia Oceania J Obstet Gynaecol 13 (1987) 481-484
43. Buckshee K., and Saha A. Relevance of transferrin receptors to gynaecological malignancy. Indian J Med Res 84 (1986) 292-296
44. Walker R.A., and Day S.J. Transferrin receptor expression in non-malignant and malignant human breast tissue. J Pathol 148 (1986) 217-224
45. Taetle R. The role of transferrin receptors in hemopoietic cell growth. Exp Hematol 18 (1990) 360-365
46. Trowbridge I.S. Transferrin receptor as a potential therapeutic target. Prog Allergy 45 (1988) 121-146
47. Trowbridge I.S., and Lopez F. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci U S A 79 (1982) 1175-1179
48. Sauvage C.A., Mendelsohn J.C., Lesley J.F., and Trowbridge I.S. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia. Cancer Res 47 (1987) 747-753
49. White S., Taetle R., Seligman P.A., Rutherford M., and Trowbridge I.S. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res 50 (1990) 6295-6301
50. Moura I.C., Lepelletier Y., Arnulf B., et al. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 103 (2004) 1838-1845
51. Ng P.P., Helguera G., Daniels T.R., et al. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood 108 (2006) 2745-2754
52. Sorokin L.M., Morgan E.H., and Yeoh G.C. Transformation-induced changes in transferrin and iron metabolism in myogenic cells. Cancer Res 49 (1989) 1941-1947